• Protocols

• A091903

  OPEN TO ACCRUAL

  Phase II Trial of Adj Nivolumab +/- Cabozantinib in Patients with Resected Mucosal Melanoma
  
  

• NRGHN014

  OPEN TO ACCRUAL

  P3 Neoadjuvant Immunotherapy w/Response-Adapted Tx vs SOC for Resectable Stage III/IV Cutaneous SCC